Levemir Use in Children Approved

May 23rd, 2012

The FDA has approved Novo Nordisk, a pioneer in diabetes care; Levemir for use in children aged two to five with type 1 diabetes.

Levemir (insulin detemir) is a long-acting recombinant human insulin, has been previously used to treat type 1 diabetes from aged five and type 2 diabetes in adults.

Now Levimir is the first and only basal insulin analog for children as young as two years. Levemir insulin and flexpen are available for adults as well as children and will cost a lot less if you buy Levemir from online Canada pharmacy.

To view the full release, please visit: http://www.multivu.com/mnr/56366-novo-nordisk-fda-approves-levemir-children-two-to-five-type-1-diabetes

In last month, Levemir was approved for pregnant women with diabetes.